dLife - Inhaled Insulin
Inhaled Insulin: The Facts
In early 2006, Exubera became the first inhaled insulin product cleared for U.S. sale – marking what was arguably the biggest advance in insulin therapy since the drug was first administered to a patient in 1922. A powdered insulin administered through the mouth via an inhaler, Exubera was approved for use in type 1 and type 2 adult patients (i.e., over 18) who take insulin for use at mealtime. But Exubera faced an uphill battle winning widespread physician and consumer adoption, and in October of 2007, manufacturer Pfizer announced that it would pull the product from its portfolio.
Other Products in the Inhaled Insulin Pipeline
There are several other inhaled insulin products and inhaler systems in various stages of product development and/or clinical trials:
Eli Lilly and Co. in partnership with Alkermes, Inc. is developing the the AIR® Inhaled Insulin System (AIR® Insulin System). It is currently in stage 3 of clinicial development and is being studied as treatment for both type 1 and type 2 diabetes.
Kos Pharmaceuticals Inc. – Metered Dose Inhaler (MDI) is continuing its inhaled insulin study.
MannKind Corp. – Technosphere Delivery System will be submitting final approval in 2008 for the new inhaled Supra-Rapid Acting insulin. It will be for mealtime insulin delivery for people with type 1 and type 2 diabetes. It is expected to be a first in a new class of medications.
Novo Nordisk Refocuses Its Activities Within Inhaled Insulin and Discontinues the Development of AERx® (Updated 01/14/08)
Expert Q & A
Keith Campbell, RPh talks about the pros and cons of inhaled insulin Last Updated: 1/31/06
See how the Exubera inhaled insulin system works. (Pfizer, Inc.)
Dr. Robert Meyer of the U.S. FDA speaks about Exubera's January 2006 approval. (Originally broadcast 1/31/06.) Listen
dLife's Janis Roszler talks to diabetes expert Dr. Steve Edelman about inhaled insulin. (Originally broadcast 1/31/06.) Listen
One in Ten AMI Patients Have Unrecognized Incident Diabetes
Two New LDL Cholesterol Drugs May Have Big Impact on Heart Disease
COBA Conference Steers Forward in the Fight Against Childhood Obesity
Google Secures Patent for Glucose-Sensing Contact Lens
Medtronic to Use GlucoSitter Artificial Pancreas Software in Future Insulin Pumps - A Big Deal!
Turkey Roulade Sugar Free Oatmeal Cookies Three Kings Bread Chicken Soup with Spinach and Wild Rice Ginger Miso Dressing Sugar Free and Dairy Free Milk Lite-Italian Vegetable Soup Beef and Onion Soup Chicken, Mint, and Cucumber Kabobs No-Bake Chocolate Kahlua Balls
My diabetes is changing. Until a few years ago, my morning readings were reasonable and within the desired range of under 100 mg/dl. About two years ago, they started slipping upwards into the less-desirable but apparently not-worrisome range of 100-110 mg/dl. Now, this was what was recorded by my Abbott Freestyle Lite meter, which is known to record at the lower end of the home-glucometer variability range, but with my A1c firmly in the high 5s and low 6s, the meter's tendency to...